MD Healthcare Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$15.7M
- Investors
-
9
MD Healthcare General Information
Description
Developer of medical therapies designed to treat cancer and immune-inflammatory-related diseases. The company's therapies are engaged in developing personalized cancer immunotherapies to treat cancer types, enabling researchers to focus on the advancement of novel drugs in areas of unmet medical needs.
Contact Information
Website
www.mdhc.krCorporate Office
- 3rd Floor, Kyungdong Mirwell City
- 741 Taejang-ro
- Gimpo, Gyeonggi
- South Korea
Corporate Office
- 3rd Floor, Kyungdong Mirwell City
- 741 Taejang-ro
- Gimpo, Gyeonggi
- South Korea
MD Healthcare Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Later Stage VC (Series B) | 04-Mar-2021 | $15.7M | Completed | Generating Revenue | ||
| 1. Early Stage VC (Series A) | 04-Apr-2017 | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
MD Healthcare Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
MD Healthcare Patents
MD Healthcare Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2024177349-A1 | Composition for preventing or treating metabolic disease, liver disease, or muscle disease comprising leuconostoc sp. bacteria-derived vesicles | Inactive | 21-Feb-2023 | ||
| WO-2024177353-A1 | Composition for prevention or treatment of metabolic disease, fibrotic disease, or muscle disease, comprising lactobacillus sp. bacteria-derived vesicles | Inactive | 21-Feb-2023 | ||
| WO-2023177208-A1 | Method for preparing lactic acid bacterium-derived extracellular vesicles with improved yield | Inactive | 18-Mar-2022 | ||
| JP-2024520165-A | Composition for preventing or treating inflammatory disease or cancer, comprising vesicles derived from leuconostoc bacteria | Pending | 07-Jun-2021 | ||
| EP-4353245-A1 | Composition for preventing or treating inflammatory diseases or cancer, comprising leuconostoc bacteria-derived vesicles | Inactive | 07-Jun-2021 | A61K35/744 |
MD Healthcare Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
MD Healthcare Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| ID Ventures (South Korea) | Venture Capital | Minority | ||
| JX Partners | Venture Capital | Minority | ||
| Korea Investment & Securities | Asset Manager | Minority | ||
| LB Investment | Venture Capital | Minority | ||
| LS Securities | Investment Bank | Minority |
MD Healthcare FAQs
-
When was MD Healthcare founded?
MD Healthcare was founded in 2014.
-
Where is MD Healthcare headquartered?
MD Healthcare is headquartered in Gimpo, South Korea.
-
What is the size of MD Healthcare?
MD Healthcare has 6 total employees.
-
What industry is MD Healthcare in?
MD Healthcare’s primary industry is Drug Discovery.
-
Is MD Healthcare a private or public company?
MD Healthcare is a Private company.
-
What is MD Healthcare’s current revenue?
The current revenue for MD Healthcare is .
-
How much funding has MD Healthcare raised over time?
MD Healthcare has raised $24.8M.
-
Who are MD Healthcare’s investors?
ID Ventures (South Korea), JX Partners, Korea Investment & Securities, LB Investment, and LS Securities are 5 of 9 investors who have invested in MD Healthcare.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
